Author: Sarah Ashley Bloch


Colleen Jonsson, PhD, to Lead New Center of Excellence Established to Combat Harmful Mosquito-Transmitted Viruses

|

Colleen Jonsson, PhD, professor and Endowed Van Vleet Chair of Excellence in Virology at the University of Tennessee Health Science Center (UTHSC), has been awarded over $21 million in funding to establish a Center of Excellence for Encephalitic Alphavirus Therapeutics program aimed at advancing the discovery and development of potent antiviral drug candidates targeting several… Read More


Researcher Junling Wang, PhD, of UTHSC Aims to Address Potential Disparities and Improve Efficiency for Medicare Part D

|

The University of Tennessee Health Science Center’s (UTHSC) Junling Wang, PhD, professor in the Department of Clinical Pharmacy and Translational Science, has been awarded over $1.4 million from the National Institutes of Health (NIH) to further her research on the equity and economic effects of medication management therapy programs. Her project titled, “Equity and Economic Effects… Read More


Marko Radic PhD of UTHSC Publishes Paper Exploring a Novel Treatment Option for Lupus

|

Marko Radic, PhD, associate professor of Microbiology, Immunology, and Biochemistry in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), has published a paper in Science Translational Medicine that explores a novel treatment option for Systemic lupus erythematosus (SLE) using a targeted immunotherapy approach. According to the Centers for Disease Control… Read More


UTHSC’s Ramesh Narayanan, PhD, Awarded $2 Million to Design Novel Tools and Medications for Prostate Cancer Patients

|

Ramesh Narayanan, PhD, associate professor in the Department of Medicine-Hematology and adjunct associate professor in the Departments of Urology and Pharmaceutical Sciences at the University of Tennessee Health Science Center (UTHSC), has been awarded over $2 million from the National Institutes of Health (NIH) to develop novel tools and next generation drugs designed to treat… Read More


UTHSC’s Jablonski Wins $1.53M Award to Study Glaucoma Mechanisms and Develop Targeted Therapies

|

Glaucoma is the leading cause of irreversible blindness in the world and affects more than three million people in the United States each year. Currently, there is no cure for this crippling disease, only the option to treat one’s symptoms. Monica M. Jablonski, PhD, professor in the Department of Ophthalmology in the College of Medicine… Read More


UTHSC’s Liza Makowski, PhD, Authors Paper on New Study Highlighting the Role of Sugar Metabolism in Heart Disease, Obesity

|

Liza Makowski, PhD, professor of Medicine in the Division of Hematology and Oncology in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), has published a paper in the Journal of Immunology that provides novel insights into the biochemistry of the sugar glucose in immune cells critical to obesity and heart… Read More


UTHSC’s Collaborative Seed Funding Program Tops $12 Million in Support for New Research Projects, Shapes New Future for Research

|

When it comes to scientific research, it is not uncommon for investigators to be collaborating only with other researchers from within their own lab, department, or College. According to Glen E. Palmer, PhD, associate professor in the College of Pharmacy at the University of Tennessee Health Science Center (UTHSC), the Collaborative Research Network (CORNET) Awards… Read More


Clinical Trials Network of Tennessee Opens First Clinical Trial

|

CTN2 marks significant milestone in its effort to grow the clinical research base at the University of Tennessee Health Science Center The Clinical Trials Network of Tennessee (CTN2) is kicking off its inaugural clinical trial, the first in the network’s efforts to grow the clinical research volume at the University of Tennessee Health Science Center… Read More